首页> 外文期刊>Journal of Clinical Microbiology >Direct Application of the INNO-LiPA Rif.TB Line-Probe Assay for Rapid Identification of Mycobacterium tuberculosis Complex Strains and Detection of Rifampin Resistance in 360 Smear-Positive Respiratory Specimens from an Area of High Incidence of Multidrug-Resistant Tuberculosis
【24h】

Direct Application of the INNO-LiPA Rif.TB Line-Probe Assay for Rapid Identification of Mycobacterium tuberculosis Complex Strains and Detection of Rifampin Resistance in 360 Smear-Positive Respiratory Specimens from an Area of High Incidence of Multidrug-Resistant Tuberculosis

机译:直接从INNO-LiPA Rif.TB线探针测定法快速鉴定结核分枝杆菌复杂菌株并检测多发性耐药结核高发地区360个涂片阳性呼吸道样本的利福平耐药性

获取原文
           

摘要

The INNO-LiPA Rif.TB assay for the identification of Mycobacterium tuberculosis complex strains and the detection of rifampin (RIF) resistance has been evaluated with 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis (MDR-TB). The sensitivity when compared to conventional identification/culture methods was 82.2%, and the specificity was 66.7%; the sensitivity and specificity were 100.0% and 96.9%, respectively, for the detection of RIF resistance. This assay has the potential to provide rapid information that is essential for the effective management of MDR-TB.
机译:已从多药高发地区的360个涂片阳性呼吸道标本中评估了用于鉴定结核分枝杆菌复杂菌株的INNO-LiPA Rif.TB分析和对利福平(RIF)耐药性的检测耐药结核病(MDR-TB)。与常规鉴定/培养方法相比,灵敏度为82.2%,特异性为66.7%;检测RIF抗性的敏感性和特异性分别为100.0%和96.9%。该测定法具有提供快速信息的潜力,这对于有效治疗耐多药结核病至关重要。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号